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Neurons and glial cells of the central nervous system (CNS) release extracellular
vesicles (EVs) to the interstitial fluid of the brain and spinal cord parenchyma.
EVs contain proteins, nucleic acids and lipids that can be taken up by, and modu-
late the behaviour of, neighbouring recipient cells. The functions of EVs have
been extensively studied in the context of neurodegenerative diseases. However,
mechanisms involved in EV-mediated neuron–glial communication under physio-
logical conditions or healthy ageing remain unclear. A better understanding of
the myriad roles of EVs in CNS homeostasis is essential for the development of
novel therapeutics to alleviate and reverse neurological disturbances of ageing.
Proteomic studies are beginning to reveal cell type-specific EV cargo signatures
that may one day allow us to target specific neuronal or glial cell populations in
the treatment of debilitating neurological disorders. This review aims to synthe-
sise the current literature regarding EV-mediated cell–cell communication in the
brain, predominantly under physiological conditions.
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Rapid and targeted communication between different
cell types of the central nervous system (CNS) is essen-
tial for optimal functioning of the brain. Glial cell
populations (approximately 33–66% of total brain cell
mass), including astrocytes, microglia and oligodendro-
cytes, serve many supportive roles for neurons, such as
insulation and nourishment, removal of waste prod-
ucts, supply of neurotransmitter precursor molecules,
protection from trauma, and act as migratory guidance
cues for neural precursor cells [1,2]. Glial cells are also
important in neural circuit maturation and the remod-
elling and pruning of synapses, both during develop-
ment and adulthood [3,4]. Both glial and neuronal cell
populations release extracellular vesicles (EVs) that
contain cargos such as proteins, nucleic acids and lipid
signalling molecules (Fig. 1). DNA, messenger RNA
(mRNA) transcripts, microRNAs (miRNA) and non-
coding RNAs (ncRNA) have been found in EVs,
which can modulate gene expression in target cells [5–
7]. Moreover, proteomic studies have found transcrip-
tional regulatory proteins packaged into EVs that can
trigger downstream signalling pathways in recipient
cells [8]. Therefore, EV-mediated communication
between neurons and glial cells likely results in both
fast and long-term changes in the mRNA transcripts
and proteome of target cells and serves as another
important method of information transfer between
neighbouring cells within functional neural ensembles.
Extracellular vesicles were once thought to be
unwanted material released by cells. However, we now
know that EVs are involved in both physiological and
pathological intercellular communication processes
and can regulate homeostatic signalling or trigger cyto-
toxic responses in target cells [5]. EVs travel from the
cell of origin through the extracellular space by diffu-
sion via interstitial fluid. Brain-derived EVs can also
travel further through the body via the cerebrospinal
fluid (CSF) [9,10] and blood [11,12]. Extraction of EVs
from CSF and blood is a reliable source of molecular
biomarkers that could be valuable in the clinical diag-
nosis of degenerative diseases [13,14]. From a biomedi-
cal research viewpoint, the study of EVs may facilitate
the noninvasive interrogation of the physiology and
pathophysiology of organ systems and tissues. It has
been shown that all CNS cell populations generate and
release EVs [15]. Although circulating EVs are capable
of crossing the blood–brain barrier (BBB) in both
directions, from the brain to the bloodstream and
vice versa, the specific molecular mechanisms involved
have not been fully elucidated [16]. A variety of meth-
ods for EV uptake by recipient cells have also been
described. The different routes include clathrin-depen-
dent endocytosis, which can be mediated by G pro-
tein-coupled receptors, and clathrin-independent
pathways, including macropinocytosis, nonspecific
lipid raft entry and receptor-mediated transcytosis
Fig. 1. Structure of exosomes and
ectosomes. The membrane-spanning
proteins, tetraspanins and integrins, are
present in both types of EV. Cholesterol,
sphingomyelin and ceramide are
segregated during the formation of
ectosomes and ILV budding.
Phosphatidylcholine and
phosphatidylethanolamine are common in
exosomes, but they are not abundant in
the plasma membrane domains, which is
reflected in the ectosome structure. DNA,
miRNA, cytoskeletal proteins and ncRNA
are all present in both exosomes and
ectosomes. Some proteins are exclusive
for exosomes, like ICAM-1. ALIX and
TSG101 are involved in the sorting of
cargo into exosomes, whereas MMPs and
CD4 are exclusive for ectosomes.
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(Fig. 2) [16,17]. Therefore, EVs may traverse endothe-
lial cells of the BBB vasculature via several distinct
mechanisms.
Extracellular vesicles can be grouped into three dif-
ferent categories based on their size and origin. Exo-
somes, the most studied type of EV, are small particles
(50–100 nm) that originate in the cytosol by budding
of intraluminal vesicles (ILVs) and are released by exo-
cytosis in the form of multivesicular bodies (MVBs;
Fig. 1, Table 1) [15,18]. Exosome cargo consists of
proteins, RNAs and lipids, and neighbouring cells use
exosomes as a method of paracrine transfer of molecu-
lar signals between cell populations. Exocytosis can be
triggered in response to an exogenous stimulus, usually
elevating cytosolic calcium concentration (i.e. regulated
secretion), thereby inducing the formation of the
SNARE protein complex, which enables both spatial
and temporal control of exocytosis [19–21]. Exocytosis
also occurs without stimulation, in a Ca2+-independent
manner (i.e. constitutive secretion) [22]. Ectosomes,
also known as microvesicles or microparticles (50–
1000 nm), are generated by outward budding from the
Fig. 2. Exosome and ectosome biogenesis and mechanisms of EV uptake. (1) Exosome biogenesis is performed via the endocytic pathway.
Transmembrane proteins (red and blue) are endocytosed and trafficked to early endosomes followed by sorting to late endosomes. Budding
of ILVs is carried out in late endosomes, leading to the formation of the MVB, which can release ILVs to the extracellular space. MVBs can
also follow a degradation pathway by fusing with lysosomes. (2) Ectosome assembly is carried out through nucleation at the plasma
membrane. Initially, transmembrane proteins (red and blue) are clustered in membrane domains leading to outward membrane budding.
Proteins accumulate in the lumen by lipidic anchors of proteins, thus enhancing membrane curvature (orange circle). Flexibility in the
cytoskeleton (grey lines) facilitates sorting of cytosolic proteins (pink) and RNA molecules (dark grey). ESCRT-III is mobilised to the plasma
membrane (green), promoting the formation of a spiral-like structure (magenta). Finally, disassembly of the spiral is mediated by ATPase
vacuolar protein sorting-associated protein 4 (orange-yellow). Different routes of EV uptake by recipient cells are shown including, (3)
clathrin-mediated endocytosis, (4) phagocytosis, (5) macropinocytosis and (6) fusion at the plasma membrane.
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plasma membrane and released into the extracellular
space in response to various stimuli (Fig. 1, Table 1)
[15,18]. Ectosomes contain cytoskeletal elements and
can be loaded with proteins and genetic material from
the cell of origin. Another type of EV is the apoptotic
bodies (500–2000 nm), which are released during cell
death [15]. Despite differences in the size and mem-
brane of origin of exosomes and ectosomes, their
assembly and release, as well as their interactions with
target cells in the extracellular spaces, follow similar
mechanisms. Details underlying the biogenesis and
release of EVs into the extracellular space (see Box 1
and 2) are presented below (Fig. 2).
Although the intercellular transfer of exosome car-
gos into the target cell occurs through fusion or endo-
cytosis, little is known about the molecular
mechanisms that control EV recognition by target
cells. Interestingly, it has been suggested that the recip-
ient cell may stimulate the secretion of EVs from
neighbouring cells, although the mechanisms behind
this type of ‘on demand’ EV release by neurons and
glia is not fully understood [23,24,25]. Despite signifi-
cant advances in our understanding of EV-mediated
intercellular communication in the brain, it is impor-
tant to note that our current knowledge is mostly lim-
ited to in vitro cell culture models. Therefore,
mechanisms underlying EV-mediated intercellular com-
munication in the intact CNS are yet to be uncovered.
There are a comprehensive literature and an increasing
number of studies on the role of EVs in the pathogen-
esis of neurodegenerative diseases [5,26], including Alz-
heimer disease [27,28,29], Parkinson disease [30] and
frontotemporal dementia [31]. However, the role of
EVs in neuron–glial communication under normal
physiological conditions remains to be elucidated.
Therefore, we review here the current body of
knowledge on EVs as mediators of cell–cell communi-
cation between neurons, astrocytes, microglia, oligo-
dendrocytes and neural stem cells (NSCs) under
physiological conditions.
Extracellular vesicle-mediated
intercellular communication in the
CNS
Characterisation of EVs that originate in the CNS is
challenging because neurons generally release low
amounts of EVs. However, several studies have found
EV proteomic signatures that can help to identify the
most likely cell of origin in the CNS. This promises to
increase our understanding of intercellular communica-
tion between neurons and glial cells [15]. To date, only
a few markers that are specific for CNS-derived EVs
have been identified. Neural cell adhesion molecule
(NCAM) and L1 cell adhesion molecule (L1CAM) are
widely used to detect and isolate CNS-derived EVs.
However, it is important to note that these markers
are not exclusive to CNS-derived EVs since they are
also expressed in the peripheral nervous system. Addi-
tionally, NCAM is expressed in the heart, adrenal
gland and peptic cells, while L1CAM is present in the
distal renal tubules [45]. In the case of astrocyte EVs,
the glutamate aspartate transporter (GLAST), and the
Na+/K+ ATPase are present in both exosomes and
ectosomes, whereas the cannabinoid receptor type 1
(CB1) is exclusive for ectosomes [46]. ALG-2-interact-
ing protein X (ALIX; also known as programmed cell
death 6 interacting protein, PDCD6IP), syntenin 1,
heat-shock proteins and the tetraspanins CD81, CD63,
CD9 are the most common ‘general’ exosome markers.
Other typical exosome markers include lysosomal-asso-
ciated membrane protein 1 (LAMP1), Flotillins 1, 2
Table 1. Major features of exosome and ectosome biogenesis.
Features Exosomes Ectosomes
Membrane origin Endosome, MVBs [15,18] Plasma membrane [15,18]
Diameter 50–100 nm [15] 50–1000 nm [15]
Assembly ESCRT [18]
ESCRT-independent pathways (ceramide, RAB31 and
tetraspanin routes) [39,42–44]
ESCRT [18], tetraspanin route [43,44]
Pinch off ESCRT-III/Vps4 [18] ESCRT-III/Vps4 [18]
Release mechanism MVB exocytosis [18] Shedding of cell membrane [18]
Markers Tetraspanins (CD63, CD9, CD81), Alix, TSG101, LAMP1,
syntenin 1, FLOT 1, FLOT 2, MFG-E8 [44,47–49]
Tetraspanins, TyA, C1q [18,47]
Segregated lipids cholesterol, sphingomyelin and ceramide, phosphatidylcholine
and phosphatidylethanolamine [18]
cholesterol, sphingomyelin and ceramide [18]
Membrane proteins Integrins, L1CAM, tetraspanins, FLOTs [44,45,47–49] Integrins, tetraspanins, MMPs, GP1b, GPIIb/IIa, P-
selectin and the integrin [18,37,47]
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Box 1. Extracellular vesicle biogenesis – ESCRT-dependent pathways
Assembly of small exosomes and larger ectosomes relies on endosomal sorting complexes required for transport
machinery (ESCRT) [18]. Exosomes can form via the endocytic pathway (Fig. 2). Vesicles generated at the plasma
membrane by endocytosis, or those that originate at the Golgi complex, can fuse with the membranes of early endo-
somes [32]. ESCRT-0 initiates vesicle budding in early endosomes by recognising and engaging ubiquitinated proteins,
while ESCRT-I and ESCRT-II complexes cluster proteins and form an ESCRT cargo-enriched zone [33]. Vesicle mat-
uration occurs via inward budding of the membrane into the lumen of endosomes, forming intraluminal vesicles
(ILVs). EV cargo is sorted and packaged into maturing vesicles with the help of ALG-2-interacting protein X (ALIX)
and tumour susceptibility gene 101 protein (TSG101) [34]. ESCRT-III assembly results in vesicle budding and the
sequestration of proteins. ESCRT-III is then disassembled by vacuolar protein sorting-associated protein 4-vesicle
trafficking 1 complex (Vps4-Vta1 complex), resulting in ILV sorting [33]. Fusion of multivesicular bodies (MVBs)
with the plasma membrane, which is mediated by a SNARE complex involving the vesicle-associated membrane pro-
tein 7 (VAMP7) and v-SNARE [20,18], results in exosome release.
In contrast, ectosomes are assembled by regulated outward budding of plasma membrane microdomains or lipid
rafts, which are enriched in cholesterol and glycosphingolipids (Fig. 2) [18,35]. The assembly of ectosome luminal
cargo is carried out through myristoylation and palmitoylation, resulting in the binding of cytoplasmic proteins to
the plasma membrane. Cytoplasmic proteins accumulate in the lumen and generate membrane curvature [18]. As
cytoskeletal tension loosens, RNA molecules and cytosolic proteins are sorted into ectosomes. The ESCRT-I subunit,
TSG101, relocates to the plasma membrane and interacts with ALIX and with arrestin domain-containing protein 1
(ARRDC1) [36]. ESCRT-III is also crucial for the pinching-off and release of ectosomes.
Membrane proteins, like tetraspanins and integrins, are present in both exosomes and ectosomes. However, others
are exclusive to certain ectosomes, such as matrix metalloproteinases (MMPs), the membrane glycoproteins GP1b
and GPIIb/IIa, P- selectin, and the macrophage-1 antigen (Mac-1) [37,18]. Intercellular adhesion molecule 1 (ICAM-
1) appears to be present exclusively in exosomes [25].
Box 2. Extracellular vesicle biogenesis – ESCRT-independent pathways
Alternative exosome biogenic mechanisms operate in parallel to ESCRT, or when ESCRTs are inactivated (Table 1)
[38]. For example, ceramide triggers the budding of ILVs into multivesicular endosomes (MVEs) by generating raft-
based microdomains, thus causing negative curvature of the membrane. The outer leaflet of the cell membrane con-
tains high concentrations of sphingolipids from which ceramides are formed, via SMase activity [39,40]. Ceramide
mixes poorly with other lipid raft components, showing self-assembling capability, which can induce the coalescence
of small microdomains into larger ceramide domains, thus promoting domain-induced budding [40,41]. In addition,
the cone-shaped structure of ceramide seems to enhance spontaneous negative membrane curvature by creating a
large distinct area between membrane leaflets [39,40].
Another ESCRT-independent pathway involves active Ras-related protein, Rab31, and the formation of ILVs and
exosomes while MVE degradation is avoided [42]. When Rab31 concentration is high in late endosomes, it can
encounter active epidermal growth factor receptor (EGFR) which, in turn, activates Rab31 via tyrosine phosphoryla-
tion. Active Rab31 then engages flotillins (FLOTs) in lipid rafts to enhance EGFR entry into MVEs to form ILVs.
To avoid MVE degradation, Rab31 recruits TBC1 domain family member 2B (TBC1D2B) to inactivate Ras-related
protein, Rab7a. This supresses the fusion of MVEs with lysosomes, thus allowing the secretion of exosomes [42].
In addition, tetraspanins are important for the sorting of proteins, mRNAs and microRNAs into EVs [43,44].
Although little is known with regard to how specific proteins or nucleic acids are routed toward EV sorting, tetraspa-
nin-enriched microdomains (TEMs) may play a role in defining the protein content. TEMs are ubiquitous specialized
membrane platforms composed of tetraspanins in close associations with transmembrane proteins and lipids, includ-
ing integrins, metalloproteinases and immunoglobulin-superfamily receptors. Evidence suggests that insertion of
CD81 into TEMs may be necessary for protein inclusion into the exosome structure [43]. TEMs act as a platform
that supports the compartmentalization of receptors and signalling proteins in the plasma membrane and facilitates
the selection of receptors and intracellular components to be exported into exosomes [43].
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(FLOTs 1, 2), tumour susceptibility gene 101 protein
(TSG101) and milk fat globule-EGF factor 8 protein
(MFG-E8) [44,47–49]. Using high-resolution mass
spectrometry-based proteomics, Chiasserini et al. [50]
generated a dataset of proteins present in EVs isolated
from human CSF and identified proteins and exo-
some-associated biomarkers of neurodegenerative dis-
eases. Indeed, to date, most research has focused on
identifying EV cargos associated with neurodegenera-
tive diseases and their potential use as diagnostic [51–
53] and therapeutic tools [54–58].
Putative neuron-derived exosomes are detectable
through the presence of L1CAM [5,59,60]. L1CAM is
a member of the immunoglobulin superfamily cell
adhesion molecules that regulate cell–cell adhesion.
L1CAM is recognised as an important component of
the ligand–receptor network involved in axonal growth
and guidance [60–62]. However, cell subtype-specific
EV markers released from distinct neuronal and glial
cell populations have not yet been defined [15]. There-
fore, specific functions for EVs produced by astrocytes,
oligodendrocytes and microglia are largely unknown.
Interestingly, only a small percentage of exosomes
carry miRNAs, suggesting that only certain exosome
subtypes contain a sufficient miRNA load to exert
gene silencing in target cells [63]. These small ncRNA
molecules seem to be particularly important for modu-
lating gene expression and regulating CNS functions
[64]. Approximately 70% of all known miRNAs are
expressed in the human brain. Although there are sev-
eral studies describing miRNAs as biomarkers of neu-
rodegenerative diseases [13], more research into
miRNAs that are secreted by the brain under physio-
logical conditions is required (Table 3).
Neuron-derived EVs modulate
synaptic plasticity
Active neurons secrete exosomes containing lipids,
proteins and RNA transcripts that can modify protein
expression, neurotransmission and neurogenesis in
neighbouring glial cells, neurons and stem cells (Fig. 3)
[65]. Moreover, exosome-mediated communication
may facilitate the transfer of information, both antero-
gradely and retrogradely, across synapses. The consti-
tutive release of exosomes from N2a neuroblastoma
cells has been studied under in vitro cell culture condi-
tions and they were found to bind indiscriminately to
rat primary hippocampal neurons and glial cells,
although they were endocytosed preferentially by the
astrocytes and oligodendrocytes. In contrast, exosomes
released by primary cortical glutamatergic neurons
into culture medium tended to preferentially bind to
hippocampal neurons at their presynaptic terminals
where they could then be endocytosed. Therefore,
in vivo there may be selective recognition receptors on
different cell types that facilitate targeted internalisa-
tion of exosomes at neuronal synapses [66]. Inter-
nalised exosomes likely modify post-transcriptional
mRNA trafficking and translation and induce local
changes in synaptic plasticity [67,68]. Goldie et al. [68]
studied the subcellular distribution of miRNA in both
resting and depolarised human neuroblastoma (SH-
SY5Y) cells. Decreased expression of miRNA was
detected in the neurites of potassium-depolarised cells,
whereas the exosomes produced by these cells were
enriched with miRNAs and microtubule-associated
protein 1B (MAP1B). Four of these miRNAs (miR-
638, -149*, -4281 and let-7e) were found to be nega-
tively regulated by repeated neuronal depolarisation.
Interestingly, these miRNAs regulate the expression of
mRNAs involved in synaptic plasticity [68]. MAP1B is
known to have essential roles in axon guidance, neu-
ronal regeneration and neurite branching [69]. MAP1B
also regulates the morphology of postsynaptic spines
on dendrites of glutamatergic neurons [70–72]. There-
fore, anterograde signalling by EVs released from
active presynaptic compartments may be involved in
regulating learning and memory formation. Presynap-
tic release of EVs can also modulate retrograde sig-
nalling by the postsynaptic cell, which may be
important during brain development, axon guidance or
synaptic plasticity [73]. For instance, synaptotagmin 4
(Syt4)-containing EVs are released from muscle cells
and communicate with presynaptic terminals of motor
neurons at the Drosophila neuromuscular junction.
Syt4 is a membrane trafficking protein and its expres-
sion is regulated by neuronal activity [74]. Syt4 loca-
lises to brain-derived neurotrophic factor-containing
vesicles in hippocampal neurons [75] and regulates
synaptic plasticity and memory formation. Moreover,
postsynaptic release of Syt4-containing exosomes may
regulate the presynaptic quantal release of neurotrans-
mitters, thus facilitating synaptic tuning [73].
Glutamatergic neurons also form a-amino-3-hy-
droxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptor-containing exosomes after bursts of synaptic
activity or ionomycin-triggered elevations in cytosolic
calcium levels [62]. The formation of AMPA receptor-
containing exosomes may be a mechanism used by
neurons to decrease AMPA receptor numbers locally
at synapses that undergo plastic changes, similar to
the well-documented phenomenon of AMPA receptor
internalisation and recycling [76]. This loss of AMPA
receptors may, therefore, be a homoeostatic mecha-
nism to adjust the strength of synapses [62]. Exosomes
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are capable of fusing with the cell membrane of post-
synaptic neurons, and therefore, the addition of func-
tional AMPA receptors to the postsynaptic bouton
will further modulate synaptic strength [66]. The pres-
ence of glutamate receptor subunits within exosomes
of neuronal origin suggests that other ion channels
may also travel from neuron-to-neuron and influence
their intrinsic properties [61]. Consistent with Lachenal
et al. [62], the presence of AMPA receptors in neuron-
derived EVs was detected by Faure et al. [61]. They
isolated and characterised exosomes of neuron- and
astrocyte-cell origins from rat primary cortical cell cul-
tures. Nineteen proteins were found, of which two are
mainly expressed in astrocytes, that is GLAST1 and
ceruloplasmin, the latter being a glycosylphosphatidyli-
nositol (GPI)-anchored ferroxidase [62]. L1CAM and
Fig. 3. EV-mediated intercellular communication in the CNS. Neuron-derived exosomes can modulate synaptic plasticity via AMPA receptor
transfer to postsynaptic terminals. Synaptic tuning may be facilitated by the retrograde transport of exosomes composed of Syt4 protein to
the presynaptic boutons. Moreover, MAP1B-loaded exosomes may influence neurite branching during brain development. Neurons also
produce exosomes loaded with miR-124a that are internalised by astrocytes, which promotes the homeostatic maintenance of
neurotransmission. Astrocytes can secrete neuromodulatory IL-1b-containing ectosomes that are internalised by neighbouring neurons.
Astrocytes also produce exosomes loaded with various proteins, including SPARC, Syn I, ApoD and NETO1 that can be internalised by
neurons and promote axon outgrowth, neuronal survival, neuroprotection and synaptogenesis, respectively. Microglia are known to produce
both exosomes and ectosomes loaded with GAPDH which is involved in neuritogenesis. Microglial ectosomes loaded with IL-1b and AEA
are internalised by neurons and are involved in neuroinflammation and the modulation of neurotransmission. Internalisation of neuronal
exosomes by microglia can trigger synaptic pruning. Exosomes produced by oligodendrocytes have been shown to provide trophic support
to neurons, enhance neuroprotection and are involved in the regulation of synaptic vesicle release. Oligodendrocyte-derived exosomes can
also be internalised by neighbouring oligodendrocytes to modulate myelination. NSCs produce EVs loaded with miRNAs, including miR-9,
Let-7 and miR-181 that trigger cytokine release from microglia and promote morphological transitions in microglial cells towards less
complex nonstellate shapes. These versatile functions of neuronal and glial-derived EVs enhance the complexity of cellular communication
in the CNS.
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AMPA receptor subunits (GluR2/3) were also found
in the exosome fractions. The presence of AMPA
receptors in neuron-derived EVs strongly suggests a
role in the modulation of synaptic plasticity.
Neuron-derived EV signalling to glial
cells
Neurons communicate with astrocytes through a vari-
ety of mechanisms, including exosome-mediated trans-
fer of miRNAs. This can regulate protein expression
in perisynaptic astrocytes which, in turn, can modulate
synaptic function and neurotransmission. For instance,
exosomes carrying small RNAs and miR-124a have
been isolated from neuron-conditioned medium and
shown to be internalised by primary astrocytes. This
causes an increase in both miR-124a and glutamate
transporter 1 (GLT-1) protein expression levels in the
target cells [77]. GLT-1 (also known as excitatory
amino acid transporter 2) is crucial for the homeo-
static maintenance of synaptic glutamate levels and for
preventing neuronal excitotoxicity [78]. Moreover, sev-
ere reductions in GLT-1 protein expression can lead to
excitotoxicity and degeneration of motor neurons in
patients with amyotrophic lateral sclerosis (ALS) and
in rodent models of the disease [77]. Interestingly, an
increase in GLT-1 protein expression was detected
after stereotaxic injection of miR-124a into the ventral
grey matter of the spinal cord of SOD1 G93A mice, a
mouse model of ALS. Therefore, neuronal exosome
cargoes may contain complementary combinations of
proteins and miRNAs that help astrocytes to maintain
homeostasis of neurotransmission in the CNS [79].
Interestingly, neuron-derived exosomes contain a dis-
tinct subset of miRNA compared to the miRNA pro-
file of the parent neuron. Men et al. [79] detected 168
miRNAs only found in neurons and a subset of 95
miRNAs present in their secreted exosomes. For exam-
ple, miR-669, miR-466, miR-297a-5p, and miR-3082-
5p were enriched in the exosomes. The authors suggest
that these miRNAs, along with the neuron-specific
miR-124-3p, are potentially internalised into astrocytes
and that miRNA-124-3p can upregulate GLT1 by sup-
pressing GLT1-inhibiting miRNAs [79].
Neuron–microglial communication also occurs via
neuron-derived exosome secretion, which can stimulate
synaptic pruning by causing the upregulation of com-
plement factors in microglia [80]. In an attempt to
identify the underlying mechanisms of this process,
Bahrini et al. [80] stimulated neuronal differentiation
and synapse formation in PC12 cells, followed by the
induction of neuronal degeneration. A mouse micro-
glial cell line (MG6) was then co-cultured with the
PC12 cells, resulting in the engulfment and phagocyto-
sis of PC12 neurites. The MG6 cells were also pre-in-
cubated with exosomes secreted by differentiated PC12
neurons following depolarisation. This caused an
increase in the removal of degenerating neurites.
Increased expression of complement component 3 in
MG6 cells was thought to be responsible for the accel-
erated removal of neurites from degenerating PC12
cells. The Cfb and C3 genes, which encode for comple-
ment factor B and complement component 3, respec-
tively, were found to be highly upregulated (56-fold
and 25-fold, respectively) in exosome-engulfed MG6
cells. Since C3 mRNA was not detected in exosomes,
but only in exosome-engulfed MG6 cells, these find-
ings suggest that neuron-derived exosomes induced (in
an undetermined way) the C3 mRNA expression in
MG6 cells, rather than the direct transfer of C3
mRNA from PC12 cells [80].
Astrocyte-derived extracellular
vesicles
Astrocytes are crucial in the regulation of CNS home-
ostasis, synaptogenesis and cognitive function [81] by
supplying trophic factors to neurons, actively clearing
excess neurotransmitter from synapses, and helping to
maintain the structure of the BBB [32]. Astrocytes also
communicate with neurons and other glial cells by
releasing gliotransmitters and neuromodulators that
regulate synaptic plasticity. Moreover, astrocytes can
release EVs containing a variety of cargos including
proteins and RNAs that can modify protein expression
in target cells. Cortical astrocytes produce ectosomes
loaded with the proinflammatory cytokine, IL-1b,
which acts as a neuromodulator in the healthy CNS
[82]. Bianco et al. [46] found that ectosome shedding
in rat primary astrocytes is triggered by acid sphin-
gomyelinase following activation of the ATP receptor,
P2X purinoceptor 7 (P2X7). When P2X7 is activated,
acid sphingomyelinase moves to the plasma membrane
resulting in the shedding and release of IL-1b-loaded
ectosomes (referred to as ‘microparticles’ in their
study). Interestingly, p38 mitogen-activated protein
kinase inhibitors reduce acid sphingomyelinase activa-
tion [46].
Astrocyte-derived EVs can also stimulate neurite
outgrowth, enhance neuronal survival and maturation
and increase neuronal excitability (Table 2). For
instance, You et al. [83] stimulated human primary
astrocytes using ATP and evaluated the effects of
astrocyte-derived EV (ADEV) internalisation on neu-
rite outgrowth and firing frequency of neurons. Label-
free quantitative proteomic studies showed the
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presence of exosomal proteins in ADEVs, including
endosomal sorting complexes required for transport
machinery (ESCRT), tetraspanins such as CD9, CD81
and CD63, and PDCD6IP (ALIX). Astrocyte-specific
proteins were also found, including glial fibrillary
acidic protein, GLAST1 and glucose transporter mem-
ber 1. Interestingly, the ADEVs were enriched with
proteins that possess GTPase activity, major histocom-
patibility complex (MHC) receptor activity, and func-
tion as cell adhesion molecules, and therefore, exert a
range of biological effects including neuronal cell
growth and homeostatic communication. Mouse pri-
mary cultured neurons exposed to these ADEVs for
three days displayed accelerated neuronal maturation
and an increase in their spiking activity [83].
Apolipoprotein D (ApoD), which is predominantly
expressed in the nervous system during normal devel-
opment and ageing [84], is also transported from astro-
cytes to neurons via EVs. ApoD is expressed by
astrocytes and myelinating cells to promote the sur-
vival of neurons by reducing free radical-generating
lipid hydroperoxides [48,85–87]. Pascua-Maestro et al.
[48] demonstrated that ApoD is transported from
astrocytes to neurons via EVs (exosomes), where it is
internalised. A reduction in neuroprotection was
detected when conditioned media from ApoD knock-
out astrocytes was incubated with the SH-SY5Y neu-
roblastoma cell line. This media only provided partial
protection against oxidative stress challenges, while
EVs from an ApoD-positive astrocytic cell line (human
astrocytoma 1321N1) exerted full neuroprotection [48].
ApoD was only internalised by SH-SY5Y neurons
when it was loaded into exosomes, resulting in a pro-
tective effect from reactive oxygen species (ROS) gen-
erated by paraquat (PQ) treatment. Interestingly, no
internalisation of the ApoD-free soluble form was
detected in neurons [48].
Synapsin I (Syn I) can also be released from murine
cortical astrocytes via exosomes upon stimulation with
high concentrations of extracellular potassium chloride
(KCl), oxygen/glucose deprivation (ischaemia) or treat-
ment with hydrogen peroxide (oxidative stress).
ADEVs containing Syn I promote neurite outgrowth
and survival of mouse hippocampal neurons [88]. Sev-
eral studies have shown that the cargo content of
ADEVs is stimulus-dependent. ADEVs are known to
be secreted constitutively and enhance neuronal sur-
vival and neurite outgrowth. However, Datta Chaud-
huri et al. [49] studied the cargo composition of
ADEVs using quantitative proteomic analysis after
subjecting astrocytes to multiple stimuli. Rat primary
astrocytes were exposed to a trophic stimulus, an
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stimulus using ATP, IL-1b and IL-10, respectively. In
ATP-stimulated ADEVs (ADEV-ATP), ribosomal pro-
tein L10 and neuropilin and tolloid-like protein 1
(NETO1) were detected, which induce neurite out-
growth [89] and regulate synaptogenesis [90], respec-
tively. In addition, dihydropyrimidinase like 2
(DPYSL2) and secreted protein acidic and cysteine
rich (SPARC) were found in ADEV-ATP. DPYSL2 is
involved in actin reorganisation in growth cones and
in dendritic patterning [91], while SPARC promotes
axon outgrowth and regulates the level of postsynaptic
AMPA receptors at maturing synapses [92]. The
unique protein cargos identified in ADEVs stimulated
by IL-10 were found to be involved with gap junctions
and neuronal cAMP-responsive element-binding pro-
tein (CREB) signalling. On the other hand, IL-1b-stim-
ulated ADEVs contained proteins that modulate
peripheral immune responses including C3, prothy-
mosin alpha (PTMA) and lysyl oxidase (LOX). These
data indicate that modulation of neuronal excitability
by astrocyte EVs is stimulus-dependent [49].
The stimulating effects of IL-1b on the formation of
EVs by astrocytes were demonstrated in a study of
brain injury in mice [93]. Intrastriatal administration
of IL-1b was found to promote EV shedding from
astrocytes, which rapidly entered into the peripheral
circulation, resulting in the induction of peripheral
acute cytokine responses (ACR). These EVs were
found to promote transmigration of leukocytes into
the brain through suppression of peroxisome prolifera-
tor-activated receptor a in hepatocytes which increased
nuclear factor jB (NF-jB) activity in the liver. NF-jB
activation induces peripheral ACR, which primes
leukocytes to transmigrate to the injury site. Hence, in
this case, ACR resulted in the induction of the inflam-
matory cytokines IL-1b, IL-6, TNFa and the chemoat-
tractant chemokine (C-C motif) ligand 2 (CCL2) in
the liver followed by the transmigration of leukocytes
to the brain injury site. In addition, IL-1b can induce
a rapid release of EVs from cultured primary astro-
cytes and promotes the formation of membrane micro-
domains enriched with monosialotetrahexosylganglioside
(GM1), nSMase2 and ceramide. These data support pre-
vious studies in which the production of ceramide by
nSMase is involved in plasma membrane fusion events
[39,94].
Similarly, Iba~nez et al. [95] demonstrated a modula-
tory role for ADEVs in the immune response. Primary
wild-type (WT) and Toll-like receptor 4 (TLR4)-knock
out (TLR4/) astrocytes were treated with ethanol to
determine whether ADEV content was modified and if
this affects neuroinflammation. After ethanol treat-
ment, there was an increase in the number of EVs
produced by WT astrocytes and an increase in inflam-
matory protein cargo, such as TLR4, NFjB-p65, IL-
1R, caspase 1, NLR family pyrin domain-containing 3
(NLRP3) and miRNAs including miR-146a, miR-182
and miR-200b (Table 3). On the other hand, there
were no changes in the number of EVs produced by
TLR4/ astrocytes, nor did their content change
when treated with ethanol. These results suggest that
secretion of EVs by astrocytes is dependent on the
TLR4 response. Additionally, ethanol-treated WT
astrocyte-derived EVs were found to be internalised by
na€ıve mouse cortical neurons resulting in an increase
in neuronal levels of the inflammatory protein
cyclooxygenase-2 (COX-2) and miRNAs (e.g. miR-
146a), as well as mRNA levels of IL-1b. This increase
in inflammatory-related proteins resulted in enhanced
neuronal cell death via apoptosis [95].
Oligodendrocyte-derived EVs (ODEVs)
Myelin formation by oligodendrocytes is controlled by
a range of extracellular factors, including signals from
the extracellular matrix and from axons. Close physi-
cal contacts between oligodendrocytes and neurons
can trigger mechanotransduction signals that promote
proper myelination, and this can enhance the long-
term survival of certain axons. Oligodendrocytes also
release EVs (ODEVs) that provide trophic support to
neurons and their secretion can be stimulated by neu-
ral activity and neurotransmitter signals [96,97]. Oligo-
dendrocyte-derived exosomes contain myelin proteins,
such as proteolipid protein (PLP), which can be used
as a marker to identify these particular EVs [98].
Frϋhbeis et al. [98] showed that ODEV secretion is
promoted by activity-dependent release of glutamate
from neurons and mediated by Ca2+ influx through N-
methyl-D-aspartic acid and AMPA receptors on oligo-
dendrocytes [98]. Oligodendrocyte-derived exosomes
were also found to be internalised by target neurons
in vitro and in vivo. Interestingly, co-culture of mouse
primary oligodendrocytes with mouse cortical neurons
and other glial cells showed that ODEVs were inter-
nalised by 21% of the mouse cortical neurons, 93% of
the mouse primary microglia, 3% of the mouse pri-
mary astrocytes and 2% of the oligodendrocytes.
In vivo, neurons can internalise ODEVs by endocyto-
sis. Moreover, when cultured in vitro under stressful
conditions, including oxidative stress (with H2O2) or
nutrient deprivation (absence of B-27 supplement),
neurons survived better when co-cultured with oligo-
dendrocytes or oligodendroglial exosomes [98]. Oligo-
dendrocyte-derived exosomes also promote the
survival of neurons under oxygen–glucose deprivation
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conditions (a model of cerebral ischaemia) [99]. Pri-
mary mouse neurons grown under these ischaemic
conditions displayed increased metabolic activity com-
pared to control neurons. This resilience to ischaemia
may be due to the transfer of superoxide dismutase
and catalase via ODEVs. ODEV treatment also pro-
moted protein kinase B activation and an increase in
the phosphorylation of CREB, glycogen synthase
kinase (GSK)-3a/b, GSK-3b and c-Jun N-terminal
kinases (JNK) in recipient neurons. Electrophysiologi-
cal studies revealed an increase in action potential fir-
ing rate in primary neurons when exposed to ODEVs.
The exosomes were isolated from both primary mouse
oligodendrocytes and the oligodendrocyte precursor
cell (OPCs) line, Oli-neu cells. Authors stated that the
increase in the firing rate is consistent with the notion
that oligodendrocyte-derived exosomes support the
metabolic activity of neurons [99]. For instance,
ODEVs increase the release of synaptic vesicles (at the
presynaptic site of neurons) through the induction of
sphingolipid metabolism and thus increase action
potentials in postsynaptic neurons. This mechanism
has been previously observed in microglia-derived
ectosomes that increase spontaneous and evoked exci-
tatory transmission in hippocampal neurons [100].
Exosomes produced by rat primary oligodendrocytes
can also signal to neighbouring OPCs to inhibit their
differentiation and thus reduce myelin formation [97].
To study whether neurons played a role in oligoden-
drocyte-derived exosome secretion, rat primary oligo-
dendrocytes were treated with neuronal conditioned
medium (NCM). Interestingly, the number of differen-
tiated oligodendrocytes increased, as well as their size
and complexity, after treatment with NCM. However,
addition of ODEVs to oligodendrocytes that were pre-
viously treated with NCM caused a decrease in NCM-
mediated cell surface area extension [97]. This inhibi-
tory effect was mediated by the Fyn-RhoA-ROCK sig-
nalling pathway, in which Baer et al. [101] have shown
to be involved in myelin-mediated inhibition of OPC
differentiation. These data show that neurons likely
control ODEV secretion to fine-tune myelination [97].
Kr€amer-Albers et al. [96] demonstrated that exosomes
secreted by mouse primary oligodendrocytes were
enriched in PLP and 20,30-cyclic-nucleotide-phosphodi-
esterase (CNP). After treatment of cell cultures with
ionomycin, there was a significant production of PLP-
containing exosomes suggesting that elevations in
cytosolic calcium levels may regulate their secretion.
Proteomic analysis of the ODEVs revealed the pres-
ence of myelin basic protein (MBP), myelin oligoden-
drocyte glycoprotein (MOG) and stress-protective
proteins such as glutathione S-transferase P and perox-
iredoxin 1 [96]. This suggests that ODEVs are likely to
Table 3. miRNA identified in EVs isolated from neurons, astrocytes, microglia and oligodendrocytes.
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be involved in regulating myelin formation, although
the mechanisms underlying how internalisation of
ODEVs by oligodendrocytes can influence myelin pro-
duction are yet to be fully elucidated.
Interestingly, parabiotic exposure of aged Wistar
rats to a youthful systemic milieu, including serum
exosomes, promotes the differentiation of OPCs, mye-
lin production, and improves remyelination in hip-
pocampal slice cultures after acute lysolecithin-induced
demyelination [102]. Serum-derived exosomes from
rats exposed to environmental enrichment (EE) exerts
a similar promyelinating effect and promotes the pro-
liferation of NSCs. Both, young and EE serum-derived
exosomes were found to be enriched in miR-219,
which is necessary to produce myelinating oligoden-
drocytes by reducing the expression of inhibitory regu-
lators of differentiation [103]. In addition, nasal
administration of exosomes from young rats enhances
myelination in the ageing rat brain [102]. Therefore,
serum-derived exosomes from young and healthy
donors could, in theory, be one day used as neurother-
apeutics to promote the repair and regeneration of the
aged and damaged CNS.
Neural stem cell-derived EVs
Extracellular vesicles derived from NSCs are promising
therapeutic tools for the treatment of neurodegenera-
tive diseases. Studies that compare cellular uptake/in-
ternalisation of EV cargo from liposomes versus
naturally packaged EV cargos will be important to
guide drug development studies [104,105]. NSC-derived
EVs have several important functions in both physio-
logical and pathological conditions [106]. They express
markers such as PDCD6IP (ALIX), TSG101, and the
tetraspanins CD63 and CD9 and package the enzyme
asparaginase-like protein 1 (Asrgl1). Therefore, NSC-
derived EVs demonstrate intrinsic enzymatic activity,
acting as independent metabolic units with asparagi-
nase activity, and can thus modify the concentrations
of nutrients in the extracellular environment and regu-
late cellular physiology [107]. NSC-derived EVs may
also influence cell growth and regeneration in the
CNS. For instance, Stevanato et al. [108] demonstrated
that NSC-derived EVs released from an immortalised
human NSC (hNSC) line contain 113 miRNAs, the
most abundant being miR-1246, miR-4488, miR-4508,
miR-4492, and miR-4516. The miR-1246 targets p53
pathway and is involved in cell growth and apoptosis
[108]. Cossetti et al. [109] demonstrated that RNA and
protein cargo contained in NSC-derived exosomes are
modified by cytokine stimulation (Th1 and Th2 cyto-
kine cocktails). The interferon gamma (IFN-c)
pathway was activated in NSCs when exposed to a
proinflammatory cytokine cocktail, which was mir-
rored in the EV cargo released. The transcription fac-
tor, signal transducer and activator of transcription 1
(STAT1), is activated by interferons which trigger the
expression of IFN-stimulated genes involved in antivi-
ral defence, tumour-suppressive functions, and also
provides resistance to DNA-damaging agents [110].
Hence, Cossetti et al. [109] showed that NSC-derived
exosomes can stimulate neuroprotective mechanisms in
target cells. Recently, Morton et al. [111] provided evi-
dence that mouse neonatal subventricular zone NSCs
release EVs that can regulate microglial morphology
and physiology and express the miRNAs (miR-9, Let-
7, miR-181). These EVs induced the transition of
microglial cells towards less complex nonstellate mor-
phologies that express CD11b and Iba1. Moreover,
NSC-derived EVs modulated transcriptional pro-
grammes and cytokine release from microglia, thus
inducing a negative feedback loop that decreased NSC
proliferation [111]. Therefore, there are likely bidirec-
tional interactions in vivo between adult-born NSCs
and microglia via the release and uptake of EVs.
Microglia-derived EVs
Microglia, the resident macrophages of the CNS, regu-
late neuroinflammation and innate immunity in the
brain and spinal cord. Microglia are the first line of
defence against pathogens, toxins and malignant cells
in the CNS and act to maintain tissue homeostasis
[112]. Hence, microglia are surveyors and monitors of
the brain parenchyma and react to danger signals.
Microglia-derived EVs (MDEVs) are an important
form of intercellular communication in the brain. Sev-
eral studies have identified aminopeptidase CD13 and
the monocarboxylate transporter 1 as specific markers
for MDEVs [112,113]. Extracellular ATP, via the acti-
vation of P2X7 receptors, is an important stimulant of
vesicle shedding in microglia. Takenouchi et al. [114]
showed that ectosomes (microvesicles) form in micro-
glial cells following activation of P2X7 receptors by
ATP, resulting in the release of glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) into the extracellular
space [114]. GAPDH is a key glycolytic enzyme
expressed on the surface of macrophages where it
functions as a transferrin receptor [108]. It is also
involved in the regulation of neuritogenesis in neurons
[115,116]. To investigate the mechanism of GAPDH
release, lipopolysaccharide (LPS)-primed MG6 mouse
microglial cells were exposed to ATP which resulted in
the formation of EVs (exosomes and ectosomes)
enriched in GAPDH. GAPDH was found to facilitate
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LPS-induced phosphorylation of p38 MAP kinase in
MG6 cells. Taken together, these findings indicate that
GAPDH release might be involved in the regulation of
neuroinflammation and/or neuritogenesis in the brain
[114].
Astrocyte-derived ATP can induce vesicle shedding
(ectosome formation) from nearby microglia, followed
by IL-1b release. Cytokine-loaded EVs secreted by
microglia are thought to coordinate inflammatory
responses across multiple regions of the brain. In addi-
tion to extracellular ATP, serotonin (5HT) also stimu-
lates EV secretion from microglia. Glebov et al. [117]
demonstrated the expression of 5HT receptors in
microglia, including 5-HT2A, 5-HT2B, and 5-HT4,
and their role in exosome secretion. A significant
increase in cytosolic Ca2+ and exosome release was
detected upon 5-HT treatment of mouse primary
microglia and the BV-2 microglial cell line. Moreover,
co-culture of microglia with embryonic stem cell-
derived serotonergic neurons stimulates exosome secre-
tion from microglia through 5-HT receptor-mediated
mechanisms [117].
Microglia-derived EVs can also modulate presynap-
tic neurotransmission via the endocannabinoid system.
Endocannabinoids are secreted in EVs produced by
microglial cells (both rat primary cells and the murine
N9 cell line). The endocannabinoid anandamide, also
known as N-arachidonoylethanolamine (AEA), is
expressed on the surface of MDEVs and can stimulate
CB1 receptors, thus inhibiting presynaptic neurotrans-
mission in GABAergic neurons [118]. Hooper et al.
[119] have shown the internalisation of microglia-
derived exosomes by neurons after EV isolation from
wingless-related integration site (Wnt)-3a-treated
microglia. Wnt-3a is a signalling protein and proto-
oncogene that displays critical roles in neurodevelop-
mental processes and neurological diseases [120]. Inter-
estingly, Wnt-3 has also been shown to stimulate
exosome secretion in microglia. Initially, carrier-free
Wnt-3a was found to be internalised into primary cul-
tured rat microglia followed by release of Wnt-3a-con-
taining exosomes from rat primary microglia [119].
The microglia-derived exosome secretion was regulated
by a GSK 3-independent mechanism. Similarly, Wnt-
3a-containing exosomes were also secreted by primary
cortical neurons upon Wnt-3a treatment. Proteomic
analyses of the microglia-derived exosomes showed the
presence of a total of 45 proteins involved in metabo-
lism, cellular architecture, protein synthesis and pro-
tein degradation, for example, GAPDH, ubiquitin,
and ribosomal subunits. The authors suggest that the
Wnt3a-containing exosomes might serve to produce
morphogen gradients during CNS development [119].
Despite the importance of microglia in the CNS, there
is still much to learn regarding the multiple roles of
MDEVs in regulating glial and neuronal function.
Concluding remarks
Extracellular vesicles function as a complex mode of
communication between neurons and glial cells of the
CNS, under both physiological and pathological
states. EVs have been implicated in important pro-
cesses including synaptic plasticity, myelination and
neurogenesis, as well as modulation of neuroinflamma-
tion. However, most studies are based on results from
cell culture of human or rodent primary cells or cell
lines. Although in vitro models have been very useful
in uncovering the mechanisms of EV binding and
internalisation by target cells, they provide only a lim-
ited understanding of physiological roles of brain EVs
in living animals. Moreover, purely in vitro studies
may provide misleading information in terms of target
cell specificity of EVs by confining the EVs to a par-
ticular and unnatural cell culture environment. There-
fore, further in vivo studies are needed for a more
reliable and complete understanding of the role of
EVs in intercellular communication in the CNS in
health and disease. There is also a paucity of research
on intercellular communication via EVs in the brain
under physiological conditions and healthy ageing.
Deciphering the role of EVs under physiological con-
ditions is crucial for developing therapies to cure or
alleviate neurological diseases. For instance, CSF-
derived EVs extracted from young healthy humans
could be administrated to older patients suffering from
neurological diseases to promote a healthier brain
physiology. However, more information on the specific
mechanisms of cell recognition and internalisation of
EVs by recipient cells is required to develop targeted
treatments. Additionally, how cargoes are unloaded
and processed by the recipient cells remains to be
unravelled. Another outstanding aspect that remains
to be revealed is how EVs cross the BBB. Mechanistic
understanding of these complex processes warrants
further investigation.
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